- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03474939
The Effect of Midazolam Premedication on Copeptine Concentration in Blood
April 18, 2019 updated by: Marek Janiak, Medical University of Warsaw
The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mazowieckie
-
Warsaw, Mazowieckie, Poland, 02-005
- I Department of Anesthesiology and Intensive Care Medical University of Warsaw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for elective surgery
- Patients with no chronić illness and considered ASA 1 by anesthesiologist
- Patients with mild and controlled chronic illness considered ASA 2 by anesthesiologist
Exclusion Criteria:
- Patient refusal
- Chronic illness requiring intense treatment or uncontrolled illness (ASA 3 or more)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: MIDAZOLAM
Patients receive midazolam 7,5mg night before and 60 minutes prior to surgery as part of preanesthetic medication
|
Midazolam Oral tablet
|
|
Placebo Comparator: PLACEBO
Patients receive 1000mg Glucose tablets night before and 60 minutes prior to surgery during premedication
|
Glucose 1000mg tablet night before surgery and 60 minutes before surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in copeptin concentration
Time Frame: 48 hours
|
Change in the concentration of copeptine measured in blood serum
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 3, 2017
Primary Completion (Actual)
March 1, 2019
Study Completion (Actual)
March 1, 2019
Study Registration Dates
First Submitted
March 16, 2018
First Submitted That Met QC Criteria
March 16, 2018
First Posted (Actual)
March 23, 2018
Study Record Updates
Last Update Posted (Actual)
April 19, 2019
Last Update Submitted That Met QC Criteria
April 18, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Kidney Diseases
- Urologic Diseases
- Endocrine System Diseases
- Pituitary Diseases
- Diabetes Insipidus
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Adjuvants, Anesthesia
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Midazolam
Other Study ID Numbers
- MIDPRECOP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preanesthetic Medication
-
Medical University of ViennaCompleted
-
Guangzhou First People's HospitalUnknown
-
Sichuan Provincial People's HospitalNot yet recruitingSedation | Dexmedetomidine | Preanesthetic Medication | Safety | Monitored Anaesthesia Care
-
RWTH Aachen UniversityCompletedPreanesthetic MedicationGermany
-
Ancor SerranoInstitut d'Investigació Biomèdica de Bellvitge; Hospital Universitari de BellvitgeCompletedBreast Neoplasms | Preanesthetic Medication | Preoperative Planning | Surgery Related Complications Rate | Risk Assesment | Surgery Scheduled | Preoperative PatientsSpain
-
Universidad de AntioquiaCompletedPostoperative Complications | Telemedicine | Anesthesia | Preoperative Care | Preanesthetic Medication | Noncardiac Surgery | Risk Assessment | Surgical Procedures | Elective Surgery CancellationColombia
-
Universitair Ziekenhuis BrusselRecruitingTonsillectomy | Preanesthetic Medication | Circumcision | Ambulatory Surgery | Inhalation Anesthesia | Dental Care | Perioperative AnxietyBelgium
-
NYU Langone HealthRobert Wood Johnson Foundation; New York City Health and Hospitals CorporationCompletedMedication Adherence | Medication ErrorsUnited States
-
Universidad Autonoma de Baja CaliforniaCompletedMedication Adherence | Medication ComplianceMexico
-
Vanderbilt University Medical CenterCompletedAdherence, Medication | Nonadherence, MedicationUnited States
Clinical Trials on Midazolam Oral Tablet
-
Diskapi Yildirim Beyazit Education and Research...Not yet recruitingPediatric Anesthesia | PremedicationTurkey (Türkiye)
-
EicOsis Human Health Inc.CompletedHealthy SubjectsNew Zealand
-
Cara Therapeutics, Inc.CompletedChronic Kidney Diseases | PruritusUnited States
-
Harmony Biosciences Management, Inc.CompletedMyotonic Dystrophy 1 | Excessive Daytime SleepinessUnited States, Canada
-
Syntrix Biosystems, Inc.National Institute on Drug Abuse (NIDA); DF/Net ResearchCompletedDiabetic Neuropathies | Neuropathic Pain | Pain, ChronicUnited States
-
Fulcrum TherapeuticsTerminated
-
EicOsis Human Health Inc.CompletedHealthy AdultsUnited States
-
Fulcrum TherapeuticsCompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, Canada, France, Spain
-
EicOsis Human Health Inc.Congressionally Directed Medical Research ProgramsRecruitingDegenerative Disc Disease | Neuropathic Pain | Spinal Stenosis | Spinal Cord Injuries | SpondylosisUnited States
-
Erzurum City HospitalNot yet recruitingPostoperative Pain | Preoperative Anxiety | Adenotonsillectomy | Surgical Stress ResponseTurkey (Türkiye)